Cargando…

A third dose of inactivated SARS-CoV-2 vaccine induces robust antibody responses in people with inadequate response to two-dose vaccination

Detalles Bibliográficos
Autores principales:	Zhou, Taicheng, Shi, Tianpei, Li, Ao, Zhu, Lingzhi, Zhao, Xinshuai, Mao, Naiyin, Qin, Wanting, Bi, Hanfang, Yang, Mei, Dai, Muxian, Liu, Fengwei, Wang, Rong, Su, Wei, Zhang, Liang, Xu, Wenbo, Wei, Jia, Zhang, Zijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362758/ https://www.ncbi.nlm.nih.gov/pubmed/35958680 http://dx.doi.org/10.1093/nsr/nwac066

Ejemplares similares

Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine
por: Huang, Ruoqiong, et al.
Publicado: (2023)

Dynamics of immune responses to inactivated COVID-19 vaccination over 8 months in China
por: Shi, Tianpei, et al.
Publicado: (2023)

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
por: Yorsaeng, Ritthideach, et al.
Publicado: (2022)

Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
por: Liu, Yihao, et al.
Publicado: (2022)

Serial negative response after standard and third (Booster) dose of COVID-19 inactivated vaccine is associated with low vitamin D levels in patients with solid cancers
por: Ma, Yifei, et al.
Publicado: (2022)

Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2022)

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Inadequate Vaccine Responses in Children With Multiple Sclerosis
por: Santoro, Jonathan D., et al.
Publicado: (2021)

Fractional-dose inactivated poliovirus vaccine, India
por: Haldar, Pradeep, et al.
Publicado: (2019)

Viral keratitis after the second and third doses of inactivated COVID-19 vaccination: A case report
por: Shan, Huimin, et al.
Publicado: (2022)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients
por: Grupper, Ayelet, et al.
Publicado: (2022)

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
por: Tangsathapornpong, Auchara, et al.
Publicado: (2023)

Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people
por: Hagiya, Hideharu, et al.
Publicado: (2022)

Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient
por: Kopel, Eran, et al.
Publicado: (2012)

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
por: Ju, Bin, et al.
Publicado: (2022)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2023)

Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2019)

Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children
por: Agrawal, Ashish, et al.
Publicado: (2020)

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
por: Yue, Lei, et al.
Publicado: (2021)

Vaccine third dose and cancer patients: necessity or luxury?
por: Pappas, G., et al.
Publicado: (2021)

Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
por: Zhang, Ali, et al.
Publicado: (2022)

Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients
por: Kanai, Daisuke, et al.
Publicado: (2022)

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
por: Joo, Yoosun, et al.
Publicado: (2023)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

Third dose of anti-SARS-CoV-2 inactivated vaccine for patients with RA: Focusing on immunogenicity and effects of RA drugs
por: Zhao, Ting, et al.
Publicado: (2022)

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human
por: Zhang, Yuwei, et al.
Publicado: (2022)

Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?
por: Di Noia, Vincenzo, et al.
Publicado: (2022)

Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with underlying medical conditions
por: Li, Chunmei, et al.
Publicado: (2022)

Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab
por: Moon, Ji Young, et al.
Publicado: (2017)

Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
por: Chaiwarith, Romanee, et al.
Publicado: (2023)

Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose
por: Mwimanzi, Francis, et al.
Publicado: (2022)

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose( )
por: Mwimanzi, Francis, et al.
Publicado: (2022)

Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine
por: Fiebelkorn, Amy Parker, et al.
Publicado: (2014)

Longitudinal age differences in humoral responses to the COVID-19 vaccine in the elderly are lost after the third dose
por: Pozo-Balado, María del Mar, et al.
Publicado: (2022)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination
por: Oskay, T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rt52dms19nmtv2vlbfl5s65hm8